Literature DB >> 10556037

Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella.

X De Bolle1, T Laurent, A Tibor, F Godfroid, V Weynants, J J Letesson, P Mertens.   

Abstract

The lipopolysaccharide (LPS) is up to now the only identified major virulence determinant of Brucella. This bacterium is responsible for brucellosis in animals and for Malta fever in humans. Several monoclonal antibodies (mAbs) directed against various LPS epitopes have been characterized. Two mAbs, named A15-6B3 and B66-2C8, directed against distinct LPS epitopes have been used to select peptides from 11 phage display libraries. The sequences of the selected peptides contain an overrepresentation of either proline or tryptophan residues when selected with either A15-6B3 or B66-2C8 mAbs, respectively. For the best binding peptides, competition with LPS for the binding to the mAb is detected, which suggests that the peptides bind to the paratope of the mAb. The phages selected from the libraries were used to immunise mice, and a weak antibody response directed against LPS has been observed. These data suggest that a subset of the selected peptides are mimotopes of the LPS epitopes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556037     DOI: 10.1006/jmbi.1999.3248

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.

Authors:  S L Harris; M K Park; M H Nahm; B Diamond
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.

Authors:  Ying Peng; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

3.  Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.

Authors:  Lourena E Costa; Mayara I S Lima; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Vivian T Martins; Mariana C Duarte; Paula S Lage; Eliane G P Lopes; Daniela P Lage; Tatiana G Ribeiro; Pedro H R Andrade; Danielle F de Magalhães-Soares; Manuel Soto; Carlos A P Tavares; Luiz R Goulart; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

4.  Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies.

Authors:  Eric L Marston; Andrea V James; J Todd Parker; John C Hart; Teresa M Brown; Trudy O Messmer; Danny L Jue; Carolyn M Black; George M Carlone; Edwin W Ades; Jacquelyn Sampson
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.

Authors:  Ayman Al-Mariri; Anne Tibor; Pascal Lestrate; Pascal Mertens; Xavier De Bolle; Jean-Jacques Letesson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.

Authors:  Madushini N Dharmasena; Shelly J Krebs; Ronald K Taylor
Journal:  Microbiology (Reading)       Date:  2009-04-23       Impact factor: 2.777

7.  Identification of peptide mimotopes of Trypanosoma brucei gambiense variant surface glycoproteins.

Authors:  Liesbeth Carolien Van Nieuwenhove; Stijn Rogé; Fatima Balharbi; Tessa Dieltjens; Thierry Laurent; Yves Guisez; Philippe Büscher; Veerle Lejon
Journal:  PLoS Negl Trop Dis       Date:  2011-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.